Welcome to our dedicated page for Nutrien SEC filings (Ticker: NTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nutrien Ltd. (NTR) SEC filings page brings together the company’s regulatory disclosures as a foreign private issuer with securities listed on the New York Stock Exchange. Nutrien files reports with the US Securities and Exchange Commission under Form 40-F and supplements these with Form 6-K current reports that furnish news releases, management’s discussion and analysis (MD&A) and interim financial statements.
Investors researching Nutrien’s filings will find that Form 6-K submissions frequently attach key documents such as quarterly earnings news releases, detailed MD&A and unaudited interim condensed consolidated financial statements prepared in accordance with International Financial Reporting Standards (IFRS) and International Accounting Standard 34 on interim reporting. These materials provide segment-level information for the Nutrien Ag Solutions retail business and the Potash, Nitrogen and Phosphate fertilizer segments, along with discussions of market outlook, guidance and non-GAAP financial measures.
Annual disclosure for Nutrien is provided through its Form 40-F filing, which incorporates the company’s annual report, audited consolidated financial statements, MD&A and annual information form. These documents, referenced in the company’s MD&A, outline its role as a global provider of crop inputs and services, describe its production, distribution and retail networks, and detail risk factors and accounting policies.
On Stock Titan, SEC filings for NTR are updated as new documents are posted to EDGAR, allowing users to track the sequence of 6-K reports related to earnings releases, strategic announcements and other material information. AI-powered summaries help explain the contents of lengthy filings by highlighting segment performance, changes in guidance, capital allocation commentary and significant strategic actions such as asset divestitures or operational changes in facilities like the Trinidad nitrogen operations.
Users can also review filings for insights into Nutrien’s capital structure, tax considerations, and its status as a foreign private issuer. Together, the raw filings and AI-generated explanations give investors a structured view of how Nutrien reports its financial results, manages its fertilizer and retail businesses, and communicates with regulators and capital markets.
Nutrien Ltd. is circulating materials for its 2026 annual meeting, furnished on a Form 6-K. Shareholders of record on March 18, 2026 can vote at a fully virtual AGM on May 6, 2026 at 1:30 p.m. CST, covering director elections, financial statements, auditor re-appointment and an advisory vote on executive pay.
The board is nominating 12 directors, 11 of whom are independent, and highlights a broad skills matrix across leadership, finance, energy, agriculture and technology. Women represent about one‑third of directors, and the board targets at least 30% female representation.
Independent directors are paid an annual retainer of $310,000, with the chair receiving $550,000, mostly in Deferred Share Units that vest on board departure. In 2025, CEO Ken Seitz received total compensation of $9.44 million, heavily weighted to long‑term incentives, and the companywide annual bonus plan paid out at 113% of target based on a unified Nutrien scorecard.
Nutrien Ltd. files a base shelf prospectus on Form F-10 to register a 37-month multi‑jurisdictional shelf for the potential issuance of common shares, preferred shares, subscription receipts, debt securities, share purchase contracts and units.
The prospectus is prepared under Canada–U.S. MJDS and financials are presented in IFRS in U.S. dollars. It discloses 480,858,831 Common Shares issued and outstanding as at March 27, 2026, recent trading prices (Cdn.$104.90 on the TSX and U.S.$75.65 on the NYSE on March 27, 2026), an exchange rate of Cdn.$1.00 = U.S.$0.7207 (March 27, 2026), and a short-term debt increase of approximately U.S.$2.2 billion from December 31, 2025 to March 27, 2026.
Nutrien Ltd. filed a Modern Slavery Report under Canada’s Fighting Against Forced Labour and Child Labour in Supply Chains Act for the year ended December 31, 2025. The report covers Nutrien and key Canadian subsidiaries involved in crop nutrient production, distribution and retail.
The company describes its global agriculture supply chain, noting most suppliers are in Canada and the US, with additional suppliers across Europe, Asia, Africa and Australia. It outlines governance structures, including Board oversight, an Audit Committee, and group policies such as a Code of Conduct, Supplier Code of Conduct and a Procurement Policy.
Nutrien reports a group-wide Integrity Program built on risk intelligence, training, speaking-up channels and investigations. Based on a 2025 risk assessment, it views modern slavery risk in its Canadian operations and key suppliers as low and states it did not identify modern slavery in its operations or supply chains. The Board approved the report, which is signed by the President and CEO.
Nutrien Ltd. filed a Form 6-K to notify investors that its 2025 Annual Report, Management’s Discussion and Analysis, Audited Consolidated Financial Statements and Annual Information Form are now available on US and Canadian securities regulators’ websites. These documents cover strategy, market environment, governance, key risks, financial results and outlook.
Nutrien also released its 2025 Sustainability Report, outlining sustainability initiatives and performance. All reports can be reviewed and downloaded from the Investor Relations section of Nutrien’s website, providing a consolidated source of business, risk and sustainability information for stakeholders.
Nutrien Ltd. reports strong 2025 results, with sales of $26,885 million and net earnings of $2,297 million for the year ended December 31, 2025, up sharply from 2024. Adjusted EBITDA reached $6,046 million, and free cash flow was $1,979 million, supported by record fertilizer sales volumes and cost savings.
Retail adjusted EBITDA was $1,736 million, Potash $2,254 million, Nitrogen $2,147 million and Phosphate $382 million. Capital expenditures declined to $2,005 million while cash used for dividends and share repurchases totaled $1,612 million. Adjusted net debt ended at $11,060 million, or 1.8x adjusted EBITDA.
Portfolio actions included divesting equity interests in Profertil and Sinofert for about $900 million in gross proceeds and launching a strategic review of the Phosphate business. For 2026, Nutrien guides Retail adjusted EBITDA between $1.75–$1.95 billion, Potash sales volumes of 14.1–14.8 million tonnes, Nitrogen volumes of 9.2–9.7 million tonnes and capital expenditures of $2.0–$2.1 billion, while targeting continued free cash flow growth and ratable share repurchases.
Nutrien Ltd. filed its Annual Report on Form 40-F for the fiscal year ended December 31, 2025. The filing incorporates the 2025 Annual Information Form, 2025 MD&A, and the 2025 Audited Annual Consolidated Financial Statements as exhibits.
Shares outstanding were 481,962,233 common shares as of December 31, 2025. The report states there were no changes in internal control over financial reporting that materially affected such controls during the period covered and identifies the Audit Committee members and an audit committee financial expert.
Nutrien Ltd. plans a renewed share repurchase program under a normal course issuer bid, allowing it to buy back up to 24,057,066 common shares, or five percent of its 481,141,322 shares outstanding as of February 17, 2026. Purchases may occur on the TSX, NYSE or other permitted trading systems between March 3, 2026 and the earlier of March 2, 2027 or completion of the program, and repurchased shares will be cancelled. Daily TSX purchases are generally capped at 430,107 shares, reflecting 25 percent of recent average daily volume. Under its prior program, Nutrien had already repurchased 8,708,901 shares at a weighted-average price of US$58.56, for a total of US$510,031,461, through open market purchases.
Nutrien Ltd. has scheduled its next annual meeting of security holders as a virtual event on May 6, 2026. Shareholders of record as of March 18, 2026 will be entitled to receive notice of the meeting and to vote.
The company will use notice-and-access for both registered and beneficial holders, meaning proxy materials will be delivered electronically, with no stratification criteria applied. Nutrien will not send proxy materials directly to non-objecting beneficial owners but will pay for delivery to objecting beneficial owners.
Nutrien Ltd. reported much stronger results for 2025, driven by higher fertilizer prices and solid volumes across its Potash, Nitrogen and Retail businesses. Full-year sales reached $26.9 billion, up 4% from 2024, while gross margin rose 11% to $8.3 billion. Net earnings climbed to $2.3 billion, compared with $0.7 billion a year earlier, and diluted net earnings per share increased to $4.66 from $1.36. Adjusted EBITDA grew 13% to $6.0 billion and adjusted net earnings per share rose 31% to $4.56, reflecting stronger underlying operations.
In the fourth quarter, net earnings were $0.58 billion, or $1.18 per diluted share, and adjusted EBITDA was $1.28 billion with adjusted EPS of $0.83. Results benefited from higher potash net selling prices, increased potash volumes and improved upstream fertilizer performance, partly offset by lower Nitrogen volumes and softer Retail earnings. Net income also included a gain on the sale of Nutrien’s 50% investment in Profertil.
For 2026, Nutrien targets Retail adjusted EBITDA of $1.75 billion to $1.95 billion, potash sales of 14.1 to 14.8 million tonnes, nitrogen sales of 9.2 to 9.7 million tonnes and capital expenditures of $2.0 to $2.1 billion, assuming an effective tax rate on adjusted net earnings of 24% to 26%.
Nutrien Ltd. is increasing cash returns to shareholders by raising its quarterly dividend and planning a new share repurchase program. The Board declared a quarterly dividend of US$0.55 per share, payable on April 16, 2026 to shareholders of record on March 31, 2026, an increase of about one percent from the prior dividend and equal to an annualized US$2.20 per share.
The Board also approved the purchase of up to five percent of issued and outstanding common shares over a twelve-month period through a normal course issuer bid, subject to acceptance by the Toronto Stock Exchange. The dividend will be paid in Canadian or US dollars depending on shareholder residency and intermediaries, with options to elect currency and direct deposit. All dividends are designated as eligible dividends under Canadian tax law.